Val-Ala-PAB-MMAE is a drug-linker conjugate for antibody-drug conjugates (ADCs), composed of the Val-Ala-PAB cleavable linker and MMAE, a potent microtubule inhibitor. It is designed to be cleaved by Cathepsin B within cancer cells, releasing MMAE to inhibit tubulin polymerization and induce apoptosis. This mechanism reduces toxicity to normal tissues while enhancing antitumor activity.
Molekulargewicht:
1037.33
Reinheit:
99.02%
CAS Nummer:
[1912408-92-4]
Formel:
C55H88N8O11
Target-Kategorie:
Drug-Linker Conjugates for ADC|||Microtubule Associated
T77883
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten